Cellectis
CLLS
#7885
Rank
NZ$0.53 B
Marketcap
NZ$5.36
Share price
-3.45%
Change (1 day)
140.83%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: NZ$0.53 Billion

As of March 2026 Cellectis has a market cap of NZ$0.53 Billion. This makes Cellectis the world's 7885th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.53 B-34.48%
2025NZ$0.82 B222.61%
2024NZ$0.25 B-26.84%
2023NZ$0.34 B126.18%
2022NZ$0.15 B-72.52%
2021NZ$0.56 B-68.26%
2020NZ$1.76 B59.56%
2019NZ$1.10 B1.5%
2018NZ$1.09 B-23.12%
2017NZ$1.41 B62.36%
2016NZ$0.87 B-44.29%
2015NZ$1.56 B180.71%
2014NZ$0.55 B585.97%
2013NZ$81.48 M

End of Day market cap according to different sources

On Mar 28th, 2026 the market cap of Cellectis was reported to be:

NZ$0.38 Billion
by Nasdaq info icon info icon
NZ$0.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$135.70 B 25,072.84%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
NZ$1.60 B 198.10%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
NZ$2.39 B 344.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.79 B 48.13%๐Ÿ‡บ๐Ÿ‡ธ USA